1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Omega Fund Management (US) Inc. Buys Immunic Inc, Sells Replimune Group Inc, Translate Bio Inc, CymaBay Therapeutics Inc

August 13, 2019 | About:

Boston, MA, based Investment company Omega Fund Management (US) Inc. (Current Portfolio) buys Immunic Inc, sells Replimune Group Inc, Translate Bio Inc, CymaBay Therapeutics Inc, Paratek Pharmaceuticals Inc, FibroGen Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Omega Fund Management (US) Inc.. As of 2019Q2, Omega Fund Management (US) Inc. owns 12 stocks with a total value of $315 million. These are the details of the buys and sells.

For the details of Omega Fund Management (US) Inc.'s stock buys and sells, go to https://www.gurufocus.com/guru/omega+fund+management+%28us%29+inc./current-portfolio/portfolioportfolio

These are the top 5 holdings of Omega Fund Management (US) Inc.
  1. Gossamer Bio Inc (GOSS) - 6,953,416 shares, 48.97% of the total portfolio.
  2. Replimune Group Inc (REPL) - 5,103,455 shares, 23.68% of the total portfolio. Shares reduced by 50%
  3. Translate Bio Inc (TBIO) - 2,437,603 shares, 9.78% of the total portfolio. Shares reduced by 50%
  4. Immunic Inc (IMUX) - 1,371,494 shares, 5.00% of the total portfolio. New Position
  5. ObsEva SA (OBSV) - 999,364 shares, 3.59% of the total portfolio.
New Purchase: Immunic Inc (IMUX)

Omega Fund Management (US) Inc. initiated holding in Immunic Inc. The purchase prices were between $7.87 and $33.2, with an estimated average price of $13.15. The stock is now traded at around $13.55. The impact to a portfolio due to this purchase was 5%. The holding were 1,371,494 shares as of .

Sold Out: CymaBay Therapeutics Inc (CBAY)

Omega Fund Management (US) Inc. sold out a holding in CymaBay Therapeutics Inc. The sale prices were between $6.05 and $13.66, with an estimated average price of $11.36.

Sold Out: Dicerna Pharmaceuticals Inc (DRNA)

Omega Fund Management (US) Inc. sold out a holding in Dicerna Pharmaceuticals Inc. The sale prices were between $10.78 and $15.9, with an estimated average price of $13.58.



Here is the complete portfolio of Omega Fund Management (US) Inc.. Also check out:

1. Omega Fund Management (US) Inc.'s Undervalued Stocks
2. Omega Fund Management (US) Inc.'s Top Growth Companies, and
3. Omega Fund Management (US) Inc.'s High Yield stocks
4. Stocks that Omega Fund Management (US) Inc. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK